BDBM586079 US11530237, Compound 260::US11542297, Compound 260

SMILES CCCN(C)C(=O)c1cnn(CC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@](C)(O)CC[C@]5(C)[C@H]4CC[C@]23C)n1

InChI Key InChIKey=OEKALAIFWCJCIB-ZSDWMTCRSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 586079   

TargetGamma-aminobutyric acid (GABA) B receptor 1(Rat)
Sage Therapeutics

US Patent
LigandPNGBDBM586079(US11530237, Compound 260 | US11542297, Compound 26...)
Affinity DataIC50: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetGamma-aminobutyric acid receptor subunit gamma-1(Rat)
Sage Therapeutics

US Patent
LigandPNGBDBM586079(US11530237, Compound 260 | US11542297, Compound 26...)
Affinity DataIC50: <10nMAssay Description:Briefly, cortices are rapidly removed following decapitation of carbon dioxide-anesthetized Sprague-Dawley rats (200-250 g). The cortices are homogen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent